To Investigate Rates Of Peritonitis In Incident Peritoneal Dialysis Patients In Australia And Perform A Pilot Study Aimed At Reducing These Rates
Funder
National Health and Medical Research Council
Funding Amount
$92,314.00
Summary
Overall aims: To establish how much variation in PD practice exists between renal units in Australia; to establish current practice in 8 units; to perform an intervention study in 8 units; to analyse registry data re peritonitis in PD patients; to conduct interviews with PD patients who have had peritonitis. Expected outcomes: To establish if practice variation is associated with peritonitis rates; to see if active guideline implementation leads to better peritonitis rates; to establish the reas ....Overall aims: To establish how much variation in PD practice exists between renal units in Australia; to establish current practice in 8 units; to perform an intervention study in 8 units; to analyse registry data re peritonitis in PD patients; to conduct interviews with PD patients who have had peritonitis. Expected outcomes: To establish if practice variation is associated with peritonitis rates; to see if active guideline implementation leads to better peritonitis rates; to establish the reasons why therapy fails.Read moreRead less
Advancement Of A Personalised Approach To Minimising Infective Complications In Cancer Care
Funder
National Health and Medical Research Council
Funding Amount
$265,138.00
Summary
Managing infections in patients with cancer have become more difficult and unpredictable because of new generation cancer therapies. Measuring the response of the immune system (immune profiling) will allow us to predict which patients will develop infection so that action such as vaccination can be taken to reduce their risk. This program will refine immune profiling to personalise infection care for cancer patients and to introduce it into hospital practice.
New Strategies To Guide Tuberculosis Elimination In High And Low-prevalence Settings
Funder
National Health and Medical Research Council
Funding Amount
$262,220.00
Summary
Tuberculosis (TB) is a bacterial disease that affects more than 10 million people worldwide each year. Dr Fox is clinical trialist with a rapidly growing international profile and demonstrated capacity to lead multi-centre studies in Asia. During this Fellowship, he will lead six studies - three in Australia and three in Vietnam –aiming to reduce the impact of TB among high-risk populations.
Eliminating Hepatitis C Transmission By Enhancing Hepatitis C Care And Treatment In Primary Health Care Settings.
Funder
National Health and Medical Research Council
Funding Amount
$1,221,831.00
Summary
In developed countries, people who inject drugs (PWID) are the group at greatest risk of hepatitis C (HCV) infection but few PWID receive HCV treatment. With the advent of highly effective non-interferon based treatments HCV elimination, although ambitious, is now being seriously considered globally. This partnership grant will explore the feasibility of eliminating HCV transmission by enhancing HCV care and treatment for PWID in primary health care settings.
The Elimination Of Hepatitis C As A Global Public Health Threat
Funder
National Health and Medical Research Council
Funding Amount
$7,001,475.00
Summary
In Australia over 230,000 people live with chronic HCV infection, with an estimated annual health care cost of over > $6.5 billion if left untreated. New highly effective HCV medications - direct acting antivirals (DAAs) have a cure rate of > 90%. DAAs will revolutionise HCV care - we can now stop HCV related deaths and transmission making HCV elimination possible. This Program Grant will directly contribute to the global response to HCV elimination and Australia achieving elimination by 2 ....In Australia over 230,000 people live with chronic HCV infection, with an estimated annual health care cost of over > $6.5 billion if left untreated. New highly effective HCV medications - direct acting antivirals (DAAs) have a cure rate of > 90%. DAAs will revolutionise HCV care - we can now stop HCV related deaths and transmission making HCV elimination possible. This Program Grant will directly contribute to the global response to HCV elimination and Australia achieving elimination by 2030.Read moreRead less
Epidemiology And Prevention Of Viral Hepatitis-related Hepatocellular Carcinoma
Funder
National Health and Medical Research Council
Funding Amount
$532,507.00
Summary
Liver cancer (HCC) is a serious global issue with high mortality. Viral hepatitis is a major risk and HCC can be prevented by early detection and treatment of hepatitis B infection. The PROLIFICA study aims to identify risks for HCC in West Africa, evaluate prevention strategies and develop simple diagnostic tests to help with HCC management in resource-poor settings. This important research will be directly translatable for HCC prevention in Australia and the Asia-Pacific region.
Randomised Controlled Trial Of Surgical Skin Preparation For Prevention Of Superficial Wound Complications In Prosthetic Hip And Knee Replacement Surgery
Funder
National Health and Medical Research Council
Funding Amount
$403,128.00
Summary
The demand for prosthetic joint replacement surgery will double over the next decade. Complications involving the surgical wound are a devastating complication of this surgery. This randomised controlled trial aims to investigate whether skin cleansing prior to surgical incision with alcoholic iodine reduces the number of patients with superficial wound complications when compared to alcoholic chlorhexidine. The study will be performed in patients undergoing orthopaedic joint replacement surgery ....The demand for prosthetic joint replacement surgery will double over the next decade. Complications involving the surgical wound are a devastating complication of this surgery. This randomised controlled trial aims to investigate whether skin cleansing prior to surgical incision with alcoholic iodine reduces the number of patients with superficial wound complications when compared to alcoholic chlorhexidine. The study will be performed in patients undergoing orthopaedic joint replacement surgery: a high volume, high cost surgery.Read moreRead less
Improving Treatment And Outcomes Of Congenital Hearing Loss At The Population Level
Funder
National Health and Medical Research Council
Funding Amount
$265,138.00
Summary
Around 600 Australian babies are born with congenital hearing loss each year. Despite great advances in early diagnosis and treatment, affected children have language and other skills well below what they can potentially achieve. My research will a) examine trends in congenital hearing loss outcomes, b) enrich existing data with novel genetic and clinical data, to enable early prediction of future outcomes to direct management, and c) discover ways to prevent hearing loss progression.